- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Toshiba and Mayo settle MRI patent suit
Toshiba America Medical Systems of Tustin, CA, and the Mayo Foundationfor Medical Education and Research of Rochester, MN, have settledlitigation relating to an MRI artifact-suppression patent grantedto Mayo in 1987. Mayo filed the suit against Toshiba
Toshiba America Medical Systems of Tustin, CA, and the Mayo Foundationfor Medical Education and Research of Rochester, MN, have settledlitigation relating to an MRI artifact-suppression patent grantedto Mayo in 1987. Mayo filed the suit against Toshiba last yearin U.S. District Court in Milwaukee (SCAN 2/14/96).
Both parties declined to disclose the terms of the settlement,although they did say that Mayo has licensed the patent to fourother companies besides Toshiba. The patent covers a techniquethat eliminates artifacts caused by flow, motion, and phase aliasingby using a series of saturation pulse sequences that are interleavedwith MRI pulse sequences.
Mayo is also involved in a dispute with Picker Internationalof Cleveland over the patent, according to Mayo attorney WayneBabler of Quarles & Brady in Milwaukee.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
